Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex
The purpose of this study is to determine the efficacy and tolerance of the association of two drugs already marketed and used to treat your disease: Arimidex速 1 Mg per day per os and Zoladex速 3,6 Mg in injections under cutaneous once per month in subjects with breast cancer.
Breast Cancer
DRUG: Anastrozole and goserelin
Determine the feasibility and efficacy of the combination of these 2 drugs in these patients
To assess clinical benefit rate, time to progression, duartion of response and safety in patients treated with the combination of these 2 drugs
The purpose of this study is to determine the efficacy and tolerance of the association of two drugs already marketed and used to treat your disease: Arimidex速 1 Mg per day per os and Zoladex速 3,6 Mg in injections under cutaneous once per month in subjects with breast cancer.